Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Nature and Science
|
October 18, 2016
ADORA2b Signaling in Cardioprotection
Jennifer Gile, Tobias Eckle
Critical Care Medicine
|
March 1, 2018
The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium
Jennifer Gile, Benjamin Scott, Tobias Eckle
Current Pharmaceutical Design
|
April 16, 2020
A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction
Jennifer Gile, Yoshimasa Oyama, Sydney Shuff, et al.
Current Pharmaceutical Design
|
July 13, 2017
Circadian MicroRNAs in Cardioprotection
Yoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
Blood Reviews
|
April 2, 2020
Magnesium: The overlooked electrolyte in blood cancers?
Jennifer Gile, Gordon Ruan, Jithma Abeykoon, et al.
Current Pharmaceutical Design
|
September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury
Yoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
JCO Precision Oncology
|
March 16, 2022
Reply to A. Rizzo et al
Jennifer Gile, Amina Jatoi, Wen Wee Ma, et al.
Journal of Medical Case Reports
|
August 12, 2025
Babesiosis-induced warm autoimmune hemolytic anemia, from infection to hemolysis: a case report
Jenna Davison, Jonah Kan, Jennifer Gile, et al.
Leukemia & Lymphoma
|
May 5, 2020
Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma
Jennifer Gile, Gordon Ruan, Jithma Abeykoon, et al.
Neurobiology of Disease
|
March 14, 2015
Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome
Franck Kalume, John C Oakley, Ruth E Westenbroek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Nature and Science
|
October 18, 2016
ADORA2b Signaling in Cardioprotection
Jennifer Gile, Tobias Eckle
Critical Care Medicine
|
March 1, 2018
The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling Delirium
Jennifer Gile, Benjamin Scott, Tobias Eckle
Current Pharmaceutical Design
|
April 16, 2020
A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction
Jennifer Gile, Yoshimasa Oyama, Sydney Shuff, et al.
Current Pharmaceutical Design
|
July 13, 2017
Circadian MicroRNAs in Cardioprotection
Yoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
Blood Reviews
|
April 2, 2020
Magnesium: The overlooked electrolyte in blood cancers?
Jennifer Gile, Gordon Ruan, Jithma Abeykoon, et al.
Current Pharmaceutical Design
|
September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury
Yoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
JCO Precision Oncology
|
March 16, 2022
Reply to A. Rizzo et al
Jennifer Gile, Amina Jatoi, Wen Wee Ma, et al.
Journal of Medical Case Reports
|
August 12, 2025
Babesiosis-induced warm autoimmune hemolytic anemia, from infection to hemolysis: a case report
Jenna Davison, Jonah Kan, Jennifer Gile, et al.
Leukemia & Lymphoma
|
May 5, 2020
Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma
Jennifer Gile, Gordon Ruan, Jithma Abeykoon, et al.
Neurobiology of Disease
|
March 14, 2015
Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome
Franck Kalume, John C Oakley, Ruth E Westenbroek, et al.
Page
of 2